Anti-Amyloid Drugs for Alzheimer’s Face a Reckoning Over What ‘Benefit’ Really Means
A new Journal of Neurology Comment argues the Alzheimer's field has avoided honestly assessing whether licensed anti-amyloid drugs deliver clinically ...
A new Journal of Neurology Comment argues the Alzheimer's field has avoided honestly assessing whether licensed anti-amyloid drugs deliver clinically ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine